By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Avalanche Biotechnologies 

665 Third Street, Suite 250

San Francisco  California  94107  U.S.A.
Phone: 650-735-1324 Fax: 650-362-1908





Company News
Avalanche Biotechnologies (AAVL) To Present At The Ophthalmology Innovation Summit At The American Academy of Ophthalmology 2014 Annual Meeting 10/9/2014 8:18:28 AM
Avalanche Biotechnologies (AAVL) To Participate In Gene Therapy Panel At The Biotechnology Industry Organization (BIO) Investor Forum 10/1/2014 8:58:56 AM
Avalanche Biotechnologies (AAVL) Appoints Industry Leader Roman G. Rubio, M.D., As Senior Vice President And Head Of Translational Medicine 9/23/2014 8:26:07 AM
Avalanche Biotechnologies (AAVL) Reports Second Quarter 2014 Financial Results 9/11/2014 7:56:41 AM
Avalanche Biotechnologies (AAVL) Announces Closing Of Initial Public Offering And Exercise Of Underwriters' Option To Purchase Additional Shares 8/5/2014 3:35:29 PM
Menlo Park's Avalanche Biotechnologies (AAVL) Rolls Onto Nasdaq, Raises $102 Million For Its IPO 7/31/2014 6:43:09 AM
Avalanche Biotechnologies Boosts IPO As 2 More Biotechs Go Public This Week 7/22/2014 6:41:08 AM
Avalanche Biotechnologies Announces Appointment Of Samuel B. Barone, M.D., As Chief Medical Officer 7/1/2014 10:56:46 AM
Avalanche Biotechnologies Announces Appointment Of Industry Veteran Linda C. Bain As Chief Financial Officer 5/20/2014 8:33:49 AM
Regeneron Pharmaceuticals, Inc. (REGN), Avalanche Biotechnologies Strike $640 Million Gene Therapy Tech Deal 5/5/2014 8:01:30 AM